Literature DB >> 9647496

Urinary excretion of Tamm-Horsfall protein and epidermal growth factor in chronic nephropathy.

O Torffvit1, P E Jørgensen, A L Kamper, N H Holstein-Rathlou, P P Leyssac, S S Poulsen, S Strandgaard.   

Abstract

Tamm-Horsfall protein (THP) and epidermal growth factor (EGF) are both synthesized by tubular cells in the distal part of the nephron and excreted with the urine. The present study examines the urinary excretion rates of the two peptides in relation to functional tubular markers in patients with chronic nephropathy. Four groups of patients with moderate to severely reduced renal function were studied: glomerulonephritis (n = 10), diabetic nephropathy (n = 11), tubulointerstitial nephropathy (n = 13), and polycystic kidney disease (n = 8). The renal function was evaluated by glomerular filtration rate (GFR) as an indicator for the general renal function, lithium clearance (C(Li)) as an indicator for proximal tubular function, and absolute distal reabsorption of sodium (ADR(Na)) as an indicator for distal tubular function. The excretion rate of EGF was rather closely correlated with GFR, C(Li) and ADR(Na) (Spearman coefficients of variation 0.88, 0.69, and 0.74, respectively). The correlations between the excretion rate of THP and GFR, C(Li) and ADR(Na) were weaker (Spearman coefficients of variation 0.68, 0.42, and 0.44). When the effect of GFR had been accounted for by multiple variance analyses, the excretion rates of the two peptides were still associated with ADR(Na) but not with C(Li). In conclusion, the urinary excretion rates of especially EGF but also those of THP were correlated with renal function and distal tubular reabsorption of sodium in patients with chronic nephropathy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9647496     DOI: 10.1159/000045020

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  4 in total

1.  The human urinary proteome reveals high similarity between kidney aging and chronic kidney disease.

Authors:  Petra Zürbig; Stéphane Decramer; Mohammed Dakna; Justyna Jantos; David M Good; Joshua J Coon; Flavio Bandin; Harald Mischak; Jean-Loup Bascands; Joost P Schanstra
Journal:  Proteomics       Date:  2009-04       Impact factor: 3.984

2.  Tamm-Horsfall protein in patients with kidney damage and diabetes.

Authors:  Joana Chakraborty; Angela A Below; Deana Solaiman
Journal:  Urol Res       Date:  2004-05

3.  Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension.

Authors:  Sandosh Padmanabhan; Olle Melander; Toby Johnson; Anna Maria Di Blasio; Wai K Lee; Davide Gentilini; Claire E Hastie; Cristina Menni; Maria Cristina Monti; Christian Delles; Stewart Laing; Barbara Corso; Gerjan Navis; Arjan J Kwakernaak; Pim van der Harst; Murielle Bochud; Marc Maillard; Michel Burnier; Thomas Hedner; Sverre Kjeldsen; Björn Wahlstrand; Marketa Sjögren; Cristiano Fava; Martina Montagnana; Elisa Danese; Ole Torffvit; Bo Hedblad; Harold Snieder; John M C Connell; Morris Brown; Nilesh J Samani; Martin Farrall; Giancarlo Cesana; Giuseppe Mancia; Stefano Signorini; Guido Grassi; Susana Eyheramendy; H Erich Wichmann; Maris Laan; David P Strachan; Peter Sever; Denis Colm Shields; Alice Stanton; Peter Vollenweider; Alexander Teumer; Henry Völzke; Rainer Rettig; Christopher Newton-Cheh; Pankaj Arora; Feng Zhang; Nicole Soranzo; Timothy D Spector; Gavin Lucas; Sekar Kathiresan; David S Siscovick; Jian'an Luan; Ruth J F Loos; Nicholas J Wareham; Brenda W Penninx; Ilja M Nolte; Martin McBride; William H Miller; Stuart A Nicklin; Andrew H Baker; Delyth Graham; Robert A McDonald; Jill P Pell; Naveed Sattar; Paul Welsh; Patricia Munroe; Mark J Caulfield; Alberto Zanchetti; Anna F Dominiczak
Journal:  PLoS Genet       Date:  2010-10-28       Impact factor: 5.917

4.  Associations of plasma uromodulin and genetic variants with blood pressure responses to dietary salt interventions.

Authors:  Ming-Fei Du; Shi Yao; Ting Zou; Jian-Jun Mu; Xiao-Yu Zhang; Gui-Lin Hu; Chao Chu; Hao Jia; Yue-Yuan Liao; Chen Chen; Dan Wang; Qiong Ma; Yu Yan; Ke-Ke Wang; Yue Sun; Ze-Jiaxin Niu; Rui-Chen Yan; Xi Zhang; Hao-Wei Zhou; Wei-Hua Gao; Hao Li; Chun-Hua Li; Ke Gao; Jie Zhang; Tie-Lin Yang; Yang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-08-07       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.